Category Archive: Uncategorized

Aug 01

Future Physicians: Celebrating the Next Steps for Kevin Armknecht and Conor Sheehan

We are incredibly proud to announce that two exceptional alumni of our research group, Kevin Armknecht and Conor Sheehan, are embarking on their next chapter as medical students this summer. Both Kevin and Conor have been instrumental to our work on antimicrobial nanotechnologies, and their acceptance into medical school is a testament to their dedication, …

Continue reading »

Jul 23

Rising Star Alert: Olivia Sayani Wins First Place at the Undergraduate 3MT! 🌟

Please join me in congratulating Olivia Sayani for winning First Place in the 2025 Summer Undergraduate 3-Minute Thesis (3MT) Competition at the University of Notre Dame! 🏆🎤In just three minutes, Olivia distilled complex research into a crisp, compelling narrative—showcasing her talent not only as a promising scientist but also as a gifted science communicator. Her …

Continue reading »

Jul 18

MTEC: From DC to the Midwest – Advancing the Frontlines of Medical Defense Innovation

I recently returned from Washington, D.C., where I had the privilege of attending the 2025 MTEC Defense Medical Innovation Summit. Hosted at Venable LLP, the two-day event was a powerhouse of collaboration, bringing together the sharpest minds from the Defense Health Agency (DHA), DARPA, and private industry to map out the future of military medicine. …

Continue reading »

May 22

Lab Secures CDMRP PRCRP Funding to Supercharge CAR-T Therapy

I am pleased to announce that our lab has been awarded a new grant from the Congressionally Directed Medical Research Programs (CDMRP) – Peer Reviewed Cancer Research Program (PRCRP). Running from 2025 to 2027, this project (Award No. HT94252510332) is titled “Multispecific Bridge Nanoparticles to Engage T Cells and Off-the-Shelf CAR-T Cells Against Antigen(+) EC …

Continue reading »

Apr 10

Fighting Superbugs in Chicago: My Talk at SFB 2025

I had an incredible time presenting at the SFB 2025 conference in Chicago! On the morning of April 10th, I had the opportunity to take the stage in the AntimicrobialBiomaterials 1 Session (3C) to discuss a major breakthrough our lab has been working on. My talk, “Wound Healing Promoted by Broad-Spectrum, Phage Structure Mimicking, Synthetic …

Continue reading »

Mar 27

A Gentleman’s Effort: Ryan Davey Leaves It All in the Ring for Bengal Bouts 2025

The lights have dimmed on another historic year of Notre Dame’s Bengal Bouts, but the impact of the fighters—both inside the ring and out—continues to resonate. Among the standout performances of the 2025 finals was the heavyweight clash featuring sophomore Ryan “The Gentleman” Davey. While the final decision didn’t go his way, Davey’s grit and …

Continue reading »

Feb 14

Congratulations to Dr. Vikram Pareek on BELS Professional Development Award!

We are thrilled to congratulate Dr. Vikram Pareek, a postdoctoral researcher in the Champion Lab at the University of Notre Dame, on receiving a 2024 BELS Supplemental Professional Development Award! This competitive award from the Bioengineering & Life Sciences (BELS) Initiative will fund his innovative project, “Analysis of antibacterial activity of phage mimicking silver nanoparticles …

Continue reading »

Dec 11

Patent Issued: Phage Mimicking Nanoparticles for Combating Antibiotic Resistance

We are excited to share that our team has been granted a new patent (U.S. Patent No. 12,161,725) for a new class of antibacterial agents: Phage Mimicking Nanoparticles. The Problem: Traditional antibiotics are struggling to keep up with adaptive, multi-drug resistant “superbugs”. Our Solution: Instead of using traditional drugs, we looked to nature. Our technology …

Continue reading »

Nov 15

Bridging Technology and Health: BIPH and Lucy Institute Launch Inaugural Health Equity Data Science Challenge

We are thrilled to announce the resounding success of the inaugural Health Equity Data Science Challenge, launched in Fall 2024 through a strategic partnership between the Berthiaume Institute for Precision Health (BIPH) and the Lucy Family Institute for Data & Society. Igniting the Spark: The BIPH Contribution This initiative was born from a vision to …

Continue reading »

Aug 21

Sustained and Controlled Antibiotics Release for Prolonged Antibacterial Action Against MRSA, and Pseudomonas aeruginosa

Congratulations to REUs Argerie Guevara (NURF’21), and Kevin Armknecht (NURF’23) and Carlie Kudary (#BIPH) on the prolonged antibacterial action formulation of standard antibiotics to tackle MRSA and P.aeruginosa. More to come this year. #AMR #GOIRISH https://doi.org/10.1093/milmed/usae079

Older posts «

» Newer posts